Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales

Acta Psychiatrica Scandinavica

Volumn 111, Issue 6, 2005, Pages 453-459

  Martiny, Klaus ^a   Lunde, M ^a   Unden M ^b   Dam, H ^c   Bech, P ^a  

^a FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

^b National Hospital ^*  (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Cross sectional studies; Light; Melancholia; Phototherapy; Randomized controlled trial; Seasonal depression; Self assessment

Indexed keywords

ANTIDEPRESSANT AGENT; MIANSERIN; OXAZEPAM; SERTRALINE;

ADULT; ANXIETY DISORDER; ARTICLE; BRIGHT LIGHT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MAJOR DEPRESSION INVENTORY; MALE; MELANCHOLIA; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PHOBIA; PHOTOTHERAPY; PRIORITY JOURNAL; PSYCHOLOGICAL GENERAL WELLBEING SCALE; PSYCHOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEASONAL AFFECTIVE DISORDER; SELF EVALUATION; SELF REPORT; SOMATIZATION; SYMPTOM; SYMPTOM CHECKLIST 90; WELLBEING;

AGE OF ONSET; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIGHT; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOTHERAPY; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 20144375210     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00532.x     Document Type: Article

References (20)

1. MARTINY K. Adjunctive bright light in non-seasonal major depression. Acta Psychiatr Scand 2004;110(Suppl. 425):1-28.
2. EMEA. The European Agency for the Evaluation of Medicinal Products. Note for guidance on Good Clinical Practice (CPMP/ICH/135/95). EMEA: London, 1997.
3. American psychiatric association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), 3rd revised edn. Washington, DC: American Psychiatric Association, 1987.
4. BECH P, RASMUSSEN NA, OLSEN LR, NOERHOLM V, ABILDGAARD W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001;66:159-164.
5. BECH P. Rating scales for psychopathology, health status and quality of life. A compendium on documentation in accordance with the DSM-III-R and WHO systems. Berlin: Springer, 1993.
6. OLSEN LR, MORTENSEN EL, BECH P. The SCL-92 validated by item response models in a Danish community sample. Acta Psychiatr Scand 2004;110:225-229.
7. BECH P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter 2004; 32:15-16.
8. RASMUSSEN AN, NORHOLM V, BECH P. The internal and external validity of The Psychological General Well-Being Schedule' (PGWB). Qual Life Newsletter 1999; 22:27.
9. BECH P, OLSEN RL, KJOLLER M, RASMUSSEN NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Meth Psychiatr Res 2003;12:85-91.
10. SHEEHAN DV, LECRUBIER Y, SHEEHAN KH. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 1998;59(Suppl. 20): 22-33.
11. LINGJAERDE O, AHLFORS UG, BECH P, DENCKER SJ, ELGEN K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987;76(Suppl. 334):1-100.
12. BROWN H, ROBIN P. Applied mixed models in medicine. West Sussex: Wiley, 1999.
13. SIEGEL S, CASTELLAN NJ. Non-parametric statistics for the behavioral sciences. New York: McGraw Hill, 1986.
14. FAYERS PM, MACHIN D. Quality of life. Assessment, analysis and interpretation. London: Wiley, 2000.
15. BECH P. Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs 2005 (in press)
16. PAYKEL ES. Life events and affective disorders. Acta Psychiatr Scand 2003;108(Suppl. 418):61-66.
17. TERMAN JS, TERMAN M, SCHLAGER D et al. Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacol Bull 1990;26:3-11.
18. FABRE LF, ABUZZAHAB FS, AMIN M et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995;38:592-602.
19. STASSEN HH, DELINI-STULA A, ANGST J. Time course of improvement under antidepressant treatment. A survival analytical approach. Eur Neuropsychopharmacol 1993; 3:127-135.
20. THUNEDBORG K, ALLERUP P, BECH P, JOYCE CRB. Development of the Repertory Grid for measurement of individual quality of life in clinical trials. Int J Meth Psychiatry Res 1993;3:48-58.